These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9742632)

  • 1. [The hypereosinophilic variant of Ph'-positive chronic myeloleukemia].
    Khoroshko ND; Mokeeva RA; Turkina AG; Arkhipova NV; Semenova EA; Zakharova AV; Kobzev IuN; Sakhibzadaeva KK; Tagiev AF
    Ter Arkh; 1998; 70(7):29-37. PubMed ID: 9742632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic and symptomatic hypereosinophilic syndromes (their comparative characteristics based on 14 cases)].
    Khoroshko ND; Mokeeva RA; Turkina AG; Semenova EA; Pivnik AV
    Ter Arkh; 1997; 69(7):26-33. PubMed ID: 9424754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eosinophilic leukemia: a rare form of Philadelphia chromosome negative chronic myeloid leukemia?].
    Telek B; Kiss J; Tóth F; Krasznai G; Ujj G; Rejtö L; Kiss A; Rák K
    Orv Hetil; 1994 May; 135(20):1087-9. PubMed ID: 8052496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Features of chronic myeloid leukemia at diagnosis. Study of a series of 134 cases].
    Jonte F; Barez A; Soto I; Rayón C; Carrera D; Coma A; Pérez Llanderal J; Arribas M
    Sangre (Barc); 1992 Oct; 37(5):345-50. PubMed ID: 1293773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
    Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
    Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
    Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
    Jha CB; Kucheria K; Choudhary VP
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome.
    Bigoni R; Cuneo A; Roberti MG; Milani R; Bardi A; Cavazzini F; Minotto C; Castoldi G
    Haematologica; 2000 May; 85(5):486-91. PubMed ID: 10800164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of interphase fluorescence in situ hybridization for determination of the tumor load in chronic myeloid leukemia].
    Du QF; Zhou SY; Liu XL; Song LL; Zhang Y
    Ai Zheng; 2003 Jun; 22(6):612-5. PubMed ID: 12948411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG; Tarpey PS; Nacheva EP
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
    Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytogenetic and molecular analysis of 1193 cases with chronic myeloid leukemia].
    Jiang DZ; Chen ZM; Lou JY; Wang YG; Liang Y; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):1-5. PubMed ID: 17649716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.
    Fugazza G; Miglino M; Bruzzone R; Quintino S; Gatti AM; Grasso R; Gobbi M; Frassoni F; Sessarego M
    J Exp Clin Cancer Res; 2004 Jun; 23(2):295-9. PubMed ID: 15354415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A molecular cytogenetic study on chromosome anomalies of chronic myeloid leukemia].
    Zhu B; Shen X; Li C; Lai X; Li Y; Shi K; Feng H; Wang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):116-8. PubMed ID: 10751535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is the cytogenetic verification of chronic myeloleukemia always obligatory?].
    Abdulkadyrov KM; Rukavitsyn OA; Bessmel'tsev SS; Martynkevich IA; Saltykova LB; Sidorova ZhIu; Blinov MN; Shcherbakova EG; Shilova ER
    Ter Arkh; 1996; 68(7):27-31. PubMed ID: 8928068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.